|
1
|
Rheaume E, Simard J, Morel Y, et al:
Congenital adrenal hyperplasia due to point mutations in the type
II 3β-hydroxysteroid dehydrogenase gene. Nature Genet. 1:239–245.
1992.
|
|
2
|
White PC and New MI: Molecular genetics of
congenital adrenal hyperplasia. Baillieres Clin Endocrinol Metab.
2:941–965. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rheaume E, Lachance Y, Zhao HF, et al:
Structure and expression of a new complementary DNA encoding the
almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta
4-isomerase in human adrenals and gonads. Mol Endocrinol.
5:1147–1157. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Johannsen TH, Mallet D, Dige-Petersen H,
et al: Delayed diagnosis of congenital adrenal hyperplasia with
salt wasting due to type II 3beta-hydroxysteroid dehydrogenase
deficiency. J Clin Endocrinol Metab. 90:2076–2080. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bongiovanni AM, Eberlein WR, Goldman AS
and New M: Disorders of adrenal steroid biogenesis. Recent Prog
Horm Res. 23:375–449. 1967.PubMed/NCBI
|
|
6
|
Simard J, Rheaume E, Mebarki F, et al:
Molecular basis of human 3β-hydroxysteroid dehydrogenase
deficiency. J Steroid Biochem Mol Biol. 53:127–138. 1995.
|
|
7
|
Reiter JC, Leveau P, Tardy V, Forest MG
and Morel Y: Diagnostic criteria for the diagnosis of
3β-hydroxysteroid dehydrogenase (3β-HSD) deficiency: lessons from
hormonal and molecular studies in 2 girls presenting with premature
pubarche. Horm Res. 53:762002.
|
|
8
|
Simard J, Moisan AM and Morel Y:
Congenital adrenal hyperplasia due to 3beta-hydroxysteroid
dehydrogenase/Delta(5)-Delta(4) isomerase deficiency. Semin Reprod
Med. 20:255–276. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lutfallah C, Wang W, Mason JI, et al:
Newly proposed hormonal criteria via genotypic proof for type II
3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol
Metab. 87:2611–2622. 2002.PubMed/NCBI
|
|
10
|
Ritzen EM, Lajic S and Wedell A: How can
molecular biology contribute to the management of congenital
adrenal hyperplasia? Horm Res. 53:34–37. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luu the V, Lachance Y, Labrie C, et al:
Full length cDNA structure and deduced amino acid sequence of human
3b-hydroxy-5-ene steroid dehydrogenase. Mol Endocrinol.
3:1310–1312. 1989.PubMed/NCBI
|
|
12
|
Cherradi N, Defay G and Chambaz EM: Dual
subcellular localization of the 3β-hydroxysteroid dehydrogenase
isomerase: characterization of the mitochondrial enzyme in the
bovine adrenal cortex. J Steroid Biochem Mol Biol. 46:773–779.
1993.
|
|
13
|
Cherradi N, Defaye G and Chambaz EM:
Characterization of the 3 beta-hydroxysteroid dehydrogenase
activity associated with bovine adrenocortical mitochondria.
Endocrinology. 134:1358–1364. 1994.
|
|
14
|
Sauer LA, Chapman JC and Dauchy RT:
Topology of 3β-hydroxy-5-enesteroid dehydrogenase/D5-D4-isomerase
in adrenal cortex mitochondria and microsomes. Endocrinology.
134:751–759. 1994.
|
|
15
|
Simard J, Durocher F, Mebarki F, et al:
Molecular biology and genetics of the 3 beta-hydroxysteroid
dehydrogenase/delta5-delta4 isomerase gene family. J Endocrinol.
150:S189–S207. 1996.PubMed/NCBI
|
|
16
|
Thomas JL, Evans BW, Blanco G, et al:
Site-directed mutagenesis identifies amino acid residues associated
with the dehydrogenase and isomerase activities of human type I
(placental) 3β-hydroxysteroid dehydrogenase/isomerase. J Steroid
Biochem Mol Biol. 66:327–334. 1998.PubMed/NCBI
|
|
17
|
Moisan AM, Ricketts ML, Tardy V, et al:
New insight into the molecular basis of 3beta-hydroxysteroid
dehydroxygenase deficiency: identification of eight mutation in the
HSD3B2 gene eleven patients from seven new families and comparison
of the functional properties of twenty-five mutant enzymes. J Clin
Endocrinol Metab. 84:4410–4425. 1999.
|
|
18
|
Miller WL and Levine LS: Molecular and
clinical advances in congenital adrenal hyperplasia. J Pediatr.
111:1–17. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Speiser PW, Dupont J, Zhu D, et al:
Disease expression and molecular genotype in congenital adrenal
hyperplasia due to 21-hydroxylase deficiency. J Clin Invest.
90:584–595. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang L, SakkaL-Alkaddour H, Chang YT,
Yang X and Pang S: A new compound heterozygous frameshift mutation
in the type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene caused
salt-wasting 3β-HSD deficiency congenital adrenal hyperplasia. J
Clin Endocrinol Metab. 81:291–295. 1996.
|
|
21
|
Moran C, Potter HD, Reyna R, Boots LR and
Azziz R: Prevalence of 3 beta-hydroxysteroid
dehydrogenase-deficient nonclassic adrenal hyperplasia in
hyperandrogenic women with adrenal androgen excess. Am J Obstet
Gynecol. 181:596–600. 1999. View Article : Google Scholar
|
|
22
|
Alos N, Mosian AM, Ward L, et al: A novel
A10E homozygous mutation in the HSD3B2 gene causing severe
salt-wasting 3beta-hydroxysteroid dehydrogenase deficiency in 46,
XX and 46, XY French-Canadians: evaluation of gonadal function
after puberty. J Clin Endocrinol Metab. 85:1968–1974. 2000.
|
